IGF2BP3 and laryngeal squamous cell carcinoma: Additionally, RBM15 may interact with Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) and collaborate in the m6A modification of TMBIM6, consequently promoting the malignant progression of laryngeal squamous cell carcinoma (25).